Prescription drug · BLA
Ovidrel (Choriogonadotropin alfa) NDC 44087-1150
Choriogonadotropin alfa 250 ug/.5mL · Injection, Solution · Subcutaneous · EMD Serono, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 44087-1150-1 | 4408711500144087115001 | 1 SYRINGE, GLASS in 1 CARTON (44087-1150-1) / .5 mL in 1 SYRINGE, GLASSMarketed from Oct 6, 2003 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ovidrel
- Generic name (nonproprietary)
- choriogonadotropin alfa
- Active ingredients
- Choriogonadotropin alfa — 250 ug/.5mL
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Labeler
- EMD Serono, Inc.NDC labeler code 44087
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 021149
- Marketing start
- Listing expires
- Other FDA classes
- Gonadotropins (Chemical structure)
- Identifiers
- Product ID 44087-1150_59d39f88-54fb-480a-979b-4d3d2c7c2cd4SPL ID 59d39f88-54fb-480a-979b-4d3d2c7c2cd4SPL set ID a683e58a-63ea-44b8-a326-1a99a537bcf2RxCUI 727505, 727507UNII 6413W06WR3
- Pharmacologic class
- Gonadotropin
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N444087115001followed by a unit qualifier and the quantityPackage 44087-1150-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Ovidrel ® PreFilled Syringe (choriogonadotropin alfa injection) is indicated for the induction of final follicular maturation and early luteinization in infertile women who have undergone pituitary desensitization and who have been appropriately pretreated with follicle stimulating hormones as part of an Assisted Reproductive Technology (ART) program such as in vitro fertilization and embryo transfer. Ovidrel ® PreFilled Syringe is also indicated for the induction of ovulation (OI) and pregnancy in anovulatory infertile patients in whom the cause of infertility is functional and not due to primary ovarian failure. Selection of Patients Before treatment with gonadotropin…
Excerpt only. Read the full label for complete information.
About NDC 44087-1150
- What is NDC 44087-1150?
- 44087-1150 is the product NDC for Ovidrel (choriogonadotropin alfa), Choriogonadotropin alfa 250 ug/.5mL injection, solution, listed with the FDA by EMD Serono, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ovidrel (Choriogonadotropin alfa).
- What is the active ingredient?
- Choriogonadotropin alfa.
- Who is the labeler?
- EMD Serono, Inc., NDC labeler code 44087. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ovidrel?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.